Related Experiment Videos

Regulatory mechanisms in breast cancer. Steroidal pure antiestrogens

Cancer Treatment and Research

|January 1, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment.

Endocrine-related cancer·2005

Inhibitors of growth factor signalling.

Endocrine-related cancer·2005

Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells.

Endocrine-related cancer·2004

The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro.

Endocrinology·2003

Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancer.

Annals of the New York Academy of Sciences·2002

Prospects for combining hormonal and nonhormonal growth factor inhibition.

Clinical cancer research : an official journal of the American Association for Cancer Research·2002

See all related articles